We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$273M
Cap. Flow %
1.9%
Top 10 Hldgs %
37.21%
Holding
1,342
New
30
Increased
738
Reduced
241
Closed
27

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$79.2M
2
DLR icon
Digital Realty Trust
DLR
+$75.4M
3
SPG icon
Simon Property Group
SPG
+$73M
4
INVH icon
Invitation Homes
INVH
+$60.9M
5
REXR icon
Rexford Industrial Realty
REXR
+$44.2M

Top Sells

Rank Stock Value
1
LAMR icon
Lamar Advertising Co
LAMR
+$81.1M
2
PSA icon
Public Storage
PSA
+$63.6M
3
DOC icon
Healthpeak Properties
DOC
+$53.3M
4
SUI icon
Sun Communities
SUI
+$47.6M
5
KIM icon
Kimco Realty
KIM
+$34.4M

Sector Composition

Rank Sector Weight
1 Real Estate 55.05%
2 Technology 11.48%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
1176
Twist Bioscience
TWST
$5.32B
$3K ﹤0.01%
210
– –
VERV
1177
DELISTED
Verve Therapeutics
VERV
$3K ﹤0.01%
221
– –
CBAY
1178
DELISTED
Cymabay Therapeutics
CBAY
$3K ﹤0.01%
341
– –
IMGN
1179
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
888
– –
INBX
1180
DELISTED
Inhibrx, Inc. Common Stock
INBX
$3K ﹤0.01%
175
– –
ACRS icon
1181
Aclaris Therapeutics
ACRS
$715M
$2K ﹤0.01%
248
– –
ALEC icon
1182
Alector
ALEC
$169M
$2K ﹤0.01%
277
– –
ALLK
1183
DELISTED
Allakos
ALLK
$2K ﹤0.01%
343
– –
AMRN
1184
Amarin Corp
AMRN
$297M
$2K ﹤0.01%
67
– –
ANAB icon
1185
AnaptysBio
ANAB
$1.54B
$2K ﹤0.01%
105
– –
AVDL
1186
DELISTED
Avadel Pharmaceuticals
AVDL
$2K ﹤0.01%
245
– –
BCYC
1187
Bicycle Therapeutics
BCYC
$269M
$2K ﹤0.01%
103
– –
CHRS icon
1188
Coherus Oncology
CHRS
$217M
$2K ﹤0.01%
262
– –
CSTL icon
1189
Castle Biosciences
CSTL
$742M
$2K ﹤0.01%
86
– –
DYN icon
1190
Dyne Therapeutics
DYN
$4.15B
$2K ﹤0.01%
210
– –
EDIT icon
1191
Editas Medicine
EDIT
$399M
$2K ﹤0.01%
277
– –
EWTX icon
1192
Edgewise Therapeutics
EWTX
$4.28B
$2K ﹤0.01%
254
– –
FATE icon
1193
Fate Therapeutics
FATE
$275M
$2K ﹤0.01%
360
– –
FDMT icon
1194
4D Molecular Therapeutics
FDMT
$502M
$2K ﹤0.01%
130
– –
LKFT
1195
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$2K ﹤0.01%
51
– –
HCM icon
1196
HUTCHMED
HCM
$1.96B
$2K ﹤0.01%
185
– –
HLVX
1197
DELISTED
HilleVax
HLVX
$2K ﹤0.01%
134
– –
HROW icon
1198
Harrow
HROW
$1.44B
$2K ﹤0.01%
110
– –
ITOS
1199
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
– –
LYEL icon
1200
Lyell Immunopharma
LYEL
$318M
$2K ﹤0.01%
46
– –
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2023 Portfolio in Review

As of Q1 2023, Daiwa Securities Group held 1,342 positions worth $14.4B, up 10% from $13B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Daiwa Securities Group opened 30 new positions and exited 27, leaving the 1,342-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 55% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2023 buy was Global X Aging Population ETF: 800,000 shares worth $21.4M.
  • Daiwa Securities Group added most to VICI Properties in Q1 2023, an estimated $79.2M increase.
  • Daiwa Securities Group's biggest Q1 2023 reduction was Lamar Advertising Co, cutting an estimated $81.1M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $15.2M.
  • Daiwa Securities Group's ten largest holdings make up 37% of its $14.4B portfolio in Q1 2023.
  • Daiwa Securities Group opened 30 new positions and closed 27 in Q1 2023.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2023, filed 2 May 2023.